Aura Biosciences | S-3: Registration statement for specified transactions by certain issuers
Aura Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aura Biosciences | 10-K: Annual report
Aura Biosciences | 8-K: Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Aura Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Plavsic Mark
Aura Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Aura Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Aura Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(7.4%),Citadel Advisors LLC(7.2%), etc.
Aura Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(8.61%),Adage Capital Partners GP, L.L.C.(8.61%), etc.
Aura Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Hopkins Janet Jill
Aura Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Feder Julie B
Aura Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer de los Pinos Elisabet
Aura Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer de los Pinos Elisabet
Aura Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Feder Julie B
Aura Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Aura Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Aura Biosciences | 8-K: Current report
Aura Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Aura Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Aura Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eventide Asset Management, LLC(11.82%),Finny Kuruvilla, M.D. Ph. D.(11.82%), etc.
No Data